DiagnosTear Technologies Inc. (CSE:DTR)

Market Cap	15.05M -45.7%
Revenue	n/a
Net Income	n/a
EPS	n/a
Shares Out	60.19M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.2900
Previous Close	0.2500
Day's Range	0.2900 - 0.2900
52-Week Range	0.2100 - 0.8800
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About DiagnosTear Technologies

DiagnosTear Technologies Inc., an ophthalmic company, develops and commercializes disruptive diagnostic solutions for eye diseases. It engages in the development of TeaRx Dry Eye, a CE-IVD approved test based on the TeaRx platform for the identification and monitoring of dry eye syndrome; TeaRx Red Eye for differential assessment of adenoviral conjunctivitis, herpetic keratitis, and allergic conjunctivitis; and TeaRx Tear Collector, a non-invasive collector of one microliter of tear fluid and subsequent dilution in assay buffer for downstream a...

• Industry: Ophthalmic Goods
• Founded: 2023
• Country: Canada
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: DTR

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Aug 10, 2026

Data Sources Report a data error